What Happened?
Belgrade, MS-based Xtant-Medical Promoted Scott Neils as Interim Chief Financial Officer
About the Company
Xtant Medical (NYSE MKT: XTNT) develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. Xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and foot and ankle surgeries. With core competencies in both biologic and non-biologic surgical technologies, Xtant can leverage its resources to successfully compete in global neurological and orthopedic surgery markets.
About the Person
Scott Neils is Interim Chief Financial Officer at Xtant Medical. Previously, Scott held various senior HR leadership roles in the industry.
Info Source
News
Short Profile